Skip to main content
Clinical Trials/CTRI/2023/11/059528
CTRI/2023/11/059528Not yet recruitingPhase 4

Clinical Study Of IRQUNNASA(SCIATICA)and its Management With Hijama Bil Shurth(WET CUPPING) - NI

Pg Department of Moalijat General Medicine0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 4
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1.Low back pain (back,buttocks,leg,foot)
  • 2.Shooting pain down towards leg
  • 3.Tingling sensation
  • 4.Partial leg numbness or weakness
  • 5.SLR test positive
  • 6.Already Diagnosed cases

Exclusion Criteria

  • 1.Pregnancy and lactation
  • 2.Who are taking anti-coagulant medications
  • 3.Who are suffering from bleeding disorders
  • 4.Any systemic illness such as liver, kidney, 5.cardiac, pulmonary diseases, mental illness.
  • 6.Spinal deformity (congenital/acquired)
  • 7.RA positive, HIV, HbsAg positive
  • 8.On contraceptive and steroid therapy
  • 9.Radiological evident cases of spinal
  • disease/injury/deformity
  • 10.Unwillingness or inability to comply the
  • requirements of the protocol

Investigators

Sponsor
Pg Department of Moalijat General Medicine

Similar Trials